Alzheimer's Disease
Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs
by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar,
by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar,
by the CNS SUMMIT DATA QUALITY MONITORING WORKGROUP CORE MEMBERS—David
by David V. Sheehan, MD, MBA; Jennifer M. Giddens; and
by Darlene M. Amado, BA; Darlene A. Beamon, BSE, MA;
by Anna Furnari, MD; Rocco Salvatore Calabrò, MD, PhD; Donatella
by Atmaram Yarlagadda, MD; Megan A. Connell, PsyD; Jayaprada Kasaraneni,
by Ronald Pies, MD; Michael H. Fisher, PhD; and C.V.
by Leslie Citrome, MD, MPH; Zhenchao Guo, PhD; Iftekhar Kalsekar,
by Adil Tumbi, MD, MPH; Amin Gilani, MD; Jonathan R.
Site Design by: Dynamic Wave Consulting